la crosse method protocol

November 2, 2016

When allergy doesn’t look like allergy

Author: Anne Hendrickson

Allergychoices recently hosted its annual provider education conference for those interested in adding or expanding their use of sublingual immunotherapy in their practices. The conference’s goal is to arm allergy providers with a sublingual immunotherapy treatment protocol that they can easily and safely put into practice so more patients can […]

More »

, ,

July 27, 2016

The Cost of Allergy – A business case for treating the cause with SLIT

Author: Ashley Johnson, Allergychoices

Allergic disease affects nearly 60 million Americans (20% of the population) and this number continues to grow. With the startling numbers of Americans affected by allergic disease, it should not be a shock that allergies are the leading medical related cause of productivity loss for businesses. According to the Harvard Business […]

More »

,

November 18, 2015

SLIT for Peanut Allergy: What we’re learning from clinical experience

Author: Mary Morris, MD, ABIM

When my father, Dr. David Morris, began offering sublingual immunotherapy (SLIT) more than four decades ago, his motivation was to offer patients who were not having success with allergy injection immunotherapy another disease-modifying option. Initially, the patients who gravitated to SLIT were mold-allergic patients who were not helped by […]

More »

, , ,